Akoustis Technologies (AKTS) Misses Q3 EPS by 14c

Akoustis Technologies (NASDAQ: AKTS) reported Q3 EPS of ($0.26), $0.14 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $7.51 million versus the consensus estimate of $8.55 million.

For earnings history and earnings-related data on Akoustis Technologies (AKTS) click here.

You May Also Be Interested In

• Wedbush Starts Aktis Oncology (AKTS) at Outperform
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Deutsche Bank monitors UK auto sales as Chinese exports grow